Benitec Biopharma

Benitec Biopharma Equity

The The Equity of Benitec Biopharma (BNTC) as of Nov 7, 2026 is 47.00 M USD. In the previous year, The Equity was 200,000.00 USD — a change of 23,400.00% (higher).

Equity

47.00 MUSD

YoY

23,400.00%

Last updated:

In 2024, Benitec Biopharma's equity was 47.00 M USD, a 23,400.00% increase from the 200,000.00 USD equity in the previous year.

The Benitec Biopharma Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2017
16.53 M USD
Jan 1, 2018
13.87 M USD
Jan 1, 2019
16.61 M USD
Jan 1, 2020
10.24 M USD
Jan 1, 2021
20.01 M USD
Jan 1, 2022
2.88 M USD
Jan 1, 2023
200,000.00 USD
Jan 1, 2024
47.00 M USD
The Benitec Biopharma Equity history
YEAREquityYoY
47.00 MUSD+23,400.00%
200,000.00USD-93.06%
2.88 MUSD-85.61%
20.01 MUSD+95.41%
10.24 MUSD-38.35%
16.61 MUSD+19.75%
13.87 MUSD-16.09%
16.53 MUSD+17.82%
14.03 MUSD-23.75%
18.40 MUSD-41.83%
31.63 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Benitec Biopharma Stock analysis

What does Benitec Biopharma do? Benitec Biopharma is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Benitec Biopharma's Equity

Benitec Biopharma's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Benitec Biopharma's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Benitec Biopharma's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Benitec Biopharma's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Benitec Biopharma’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Benitec Biopharma stock

The Equity of Benitec Biopharma is 47.00 M USD in 2024.

The Equity of Benitec Biopharma changed from 200,000.00 USD to 47.00 M USD, representing a 23,400.00% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Benitec Biopharma since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Benitec Biopharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Benitec Biopharma

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Benitec Biopharma